DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Finn RS, Crown J, Lang I. et al.
Overall survival results from the randomized phase II study of palbociclib (P) in combination with letrozole (L) vs. letrozole alone for frontline treatment of ER+/HER2- advanced breast cancer (PALOMA-1; TRIO-18).
J Clin Oncol 2017;
35 (Suppl.) Abstr. 1001
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.